4//SEC Filing
Anthera Pharmaceuticals Inc 4
Accession 0001214659-13-003732
CIK 0001316175operating
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 9:17 PM ET
Size
5.4 KB
Accession
0001214659-13-003732
Insider Transaction Report
Form 4
ODINK DEBRA
VP, Pharmaceutical R&D
Transactions
- Tax Payment
Common Stock
2013-06-30$0.49/sh−2,248$1,102→ 75,074 total
Holdings
- 99,937(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]Shares forfeited in lieu of payment of tax liability in connection with the vesting of 5,000 performance shares, which represent the portion of the Reporting Person's 2010 performance share award.
Documents
Issuer
Anthera Pharmaceuticals Inc
CIK 0001316175
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001316175
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 9:17 PM ET
- Size
- 5.4 KB